Case Report
Isolated bilateral metastatic mass of malignant melanoma as shown by F-18 Fluorodeoxyglocose Positron Emission Tomography/Computed Tomography
Abstract
Melanoma of unknown primary is the diagnostic challenge as well as is associated with poor prognosis for the patient. We present a 79 years old male patient who was presented with hypermetabolic adrenal mass lesions. The biopsy results shown metastatic malignant melanoma.
References
- Drouet, C., Morel, O., & Boulahdour, H. (2017). Bilateral Huge Incidentalomas of Isolated Adrenal Metastases From Unknown Primary Melanoma Revealed by 18F-FDG PET/CT. Clinical nuclear medicine, 42(1), e51–e53. https://doi.org/10.1097/RLU.0000000000001417
- Seshadri, N., Wat, J., & Balan, K. (2006). Bilateral adrenal metastases from malignant melanoma: concordant findings on (18)F-FDG and (18)F-FDOPA PET. European journal of nuclear medicine and molecular imaging, 33(7), 854–855. https://doi.org/10.1007/s00259-006-0101-y
- Bertagna, F., Biasiotto, G., Rodella, C., Werner, T., Giubbini, R., & Alavi, A. (2009). Massive bilateral adrenal gland metastases from melanoma diagnosed by F18-FDG-PET/CT. Japanese journal of radiology, 27(9), 392–393. https://doi.org/10.1007/s11604-009-0358-8
- Kumar, R., Mavi, A., Bural, G., & Alavi, A. (2005). Fluorodeoxyglucose-PET in the management of malignant melanoma. Radiologic clinics of North America, 43(1), 23–33. https://doi.org/10.1016/j.rcl.2004.09.011
- Dimitrakopoulou-Strauss, A., Strauss, L. G., & Burger, C. (2001). Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42(2), 248–256.
Year 2024,
Volume: 4 Issue: 1, 4 - 6, 14.05.2024
Abstract
References
- Drouet, C., Morel, O., & Boulahdour, H. (2017). Bilateral Huge Incidentalomas of Isolated Adrenal Metastases From Unknown Primary Melanoma Revealed by 18F-FDG PET/CT. Clinical nuclear medicine, 42(1), e51–e53. https://doi.org/10.1097/RLU.0000000000001417
- Seshadri, N., Wat, J., & Balan, K. (2006). Bilateral adrenal metastases from malignant melanoma: concordant findings on (18)F-FDG and (18)F-FDOPA PET. European journal of nuclear medicine and molecular imaging, 33(7), 854–855. https://doi.org/10.1007/s00259-006-0101-y
- Bertagna, F., Biasiotto, G., Rodella, C., Werner, T., Giubbini, R., & Alavi, A. (2009). Massive bilateral adrenal gland metastases from melanoma diagnosed by F18-FDG-PET/CT. Japanese journal of radiology, 27(9), 392–393. https://doi.org/10.1007/s11604-009-0358-8
- Kumar, R., Mavi, A., Bural, G., & Alavi, A. (2005). Fluorodeoxyglucose-PET in the management of malignant melanoma. Radiologic clinics of North America, 43(1), 23–33. https://doi.org/10.1016/j.rcl.2004.09.011
- Dimitrakopoulou-Strauss, A., Strauss, L. G., & Burger, C. (2001). Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42(2), 248–256.
There are 5 citations in total.
Details
| Primary Language | English |
|---|---|
| Subjects | Dermatology, Gastroenterology and Hepatology, Nuclear Medicine, Pathology |
| Journal Section | Case Report |
| Authors | |
| Submission Date | April 4, 2024 |
| Acceptance Date | May 14, 2024 |
| Publication Date | May 14, 2024 |
| Published in Issue | Year 2024 Volume: 4 Issue: 1 |